Bridge Animal Referral Center
Specialty hospital / research center
3 current cancer treatment or research opportunities
About Bridge Animal Referral Center
Bridge Animal Referral Center is a veterinary oncology and surgical referral hospital in Edmonds, Washington. Its current clinical-trials roster describes active EGFR/HER2 peptide-vaccine enrollment for selected canine cancers and separate investigational treatments for superficial tumors.
Bridge clinical trials →
Who the current listings are forDogs and cats
Cancer types currently listedHemangiosarcoma, Mast Cell Tumor, Oral Melanoma, Oral Squamous Cell Carcinoma, Osteosarcoma, Soft Tissue Sarcoma, Squamous Cell Carcinoma, Urothelial Carcinoma
Current options at Bridge Animal Referral Center
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Gold nanoparticle photothermal treatment for selected superficial tumors
Bridge Animal Referral Center · USA
Active enrollment — eligible superficial gross tumors
What is being offered: Intravenous gold nanoparticles followed by near-infrared laser heating of the superficial tumor; BARC describes one heat session for smaller lesions and commonly two to three for larger sarcomas.
Who may qualify: Active tumor required; Measurable
Costs / coverage: Current BARC enrollment page does not specify costs or coverage. An older BARC page mentions support for different, narrower cohorts; those amounts cannot be assumed to apply to this enrollment.
Contact: Bridge Animal Referral Center, Edmonds — 425-697-2272
Location
- Bridge Animal Referral Center, 8401 Main St, Edmonds, WA 98026, Edmonds, WA
Official study / enrollment information →
Experimental EGFR/HER2 tumor vaccine
Therajan / participating veterinary oncology centers · USA
Currently enrolling at nine confirmed sites; Chicago, Richmond and Missouri are not enrolling
What is being offered: USDA-regulated EGFR/HER2 peptide-vaccine study led by Therajan. The current Canine Cancer Alliance status page identifies nine locations without a non-enrolling warning: Ventura, Edmonds, Pullman, Salt Lake City, Cleveland, Pittsburgh, Cincinnati, Phoenix and Stamford. Its same roster marks Chicago, Richmond and Columbia, Missouri as currently not enrolling. Stamford was separately confirmed on Veterinary Cancer Concierge Services' current trial page, which provides its intake pathway, eligibility materials and appointment location. Site-specific eligibility, scheduling and costs vary; MedVet restrictions apply only to its hospitals. Bridge also considers pulmonary carcinoma and high-grade mast cell tumor after records review, but those site-only indications are not mapped to the shared protocol record.
Who may qualify: Anticipated survival over 3 months; Standard of care therapy; Histology or long bone osa exception
May not qualify if: Other immunotherapy; Alternative therapy; Other clinical study
Costs / coverage: The investigational vaccine is provided at no charge; site visits, conventional treatment, administration and monitoring may be owner-paid. VCCS publishes a $695 charge for each vaccine appointment plus required testing. Confirm exact site-specific costs before enrollment.
Contact: Hope Veterinary Oncology — 805-626-6551; Bridge Animal Referral Center — 425-697-2272; Washington State University — 509-335-0711; MedVet Clinical Studies — clinicalstudies@medvet.com; MedVet Pittsburgh — oncology.pittsburgh@medvet.com; IVO — 602-841-0626; Veterinary Cancer Concierge Services — info@vetcancerconcierge.com.
Location
- Bridge Animal Referral Center, 8401 Main St, Edmonds, WA 98026, Edmonds, WA
Official study / enrollment information →
Intratumoral long-acting carboplatin for canine superficial squamous cell carcinoma
Bridge Animal Referral Center · USA
Active enrollment at BARC for non-metastatic superficial squamous cell carcinoma
What is being offered: Intratumoral injection of a newly formulated lower-dose carboplatin designed for long-acting local activity.
Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Measurable; Min tumor cm: 1; No metastasis
May not qualify if: Prior chemo; Prior immunotherapy; Prior local radiation
Costs / coverage: Fully funded: BARC states that study treatments and associated procedures have no cost to the owner.
Contact: Bridge Animal Referral Center, Edmonds — 425-697-2272
Location
- Bridge Animal Referral Center, 8401 Main St, Edmonds, WA 98026, Edmonds, WA
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
